Results 201 to 210 of about 379,741 (354)

Dimethyl fumarate combined with cisplatin at subcytotoxic doses sensitizes cervical cancer toward ferroptosis and apoptosis through GSH restriction and p53 (re)activation

Molecular Oncology, EarlyView.
Dimethyl fumarate (DMF) reduces growth of HPV‐positive cervical cancer spheroids and induces ferroptosis in cervical cancer cells via blocking SLC7A11/Glutathione (GSH) axis. Combination of subcytotoxic doses of DMF and cisplatin (CDDP) further suppresses spheroid growth and drives cell death in 2D culture models.
Carolina Punziano, Giuseppina Minopoli, Simona Romano, Laura Marrone, Katia Aquilano, Maria Lina Tornesello, Raffaella Faraonio   +6 more
wiley   +1 more source

Medicina occidental y otras alternativas: ¿es posible su complementariedad? Reflexiones conceptuales

Cadernos de Saúde Pública
El presente documento hace parte de una serie de reflexiones sobre el abordaje intercultural de los sistemas de salud y las políticas públicas que le corresponden, provocadas por el estudio de dos hospitales mixtos (interculturales) creados en áreas ...
María Beatriz Duarte Gómez
doaj  

Scale for Assessing Understanding of Benefits and Risks of Using Complementary Therapies in Diabetes Management: Psychometric Evaluation. [PDF]

J Nurs Res
Chang HY, Huang YY, Lo CL.
europepmc   +1 more source

Targeted modulation of IGFL2‐AS1 reveals its translational potential in cervical adenocarcinoma

Molecular Oncology, EarlyView.
Cervical adenocarcinoma patients face worse outcomes than squamous cell carcinoma counterparts despite similar treatment. The identification of IGFL2‐AS1's differential expression provides a molecular basis for distinguishing these histotypes, paving the way for personalized therapies and improved survival in vulnerable populations globally.
Ricardo Cesar Cintra, Lucca Paolo Hsu Helmich, Daniel Rodrigues de Bastos, Laura Sichero, Patrícia Savio de Araujo‐Souza, Fabio Passetti, Luisa Lina Villa   +6 more
wiley   +1 more source

Complementary therapies in early breast cancer: Oncologists' evidence-based decisions in a Southeast European vignette survey. [PDF]

Biomol Biomed
Buhovac T, Bajić Ž, Nalbani M, Popović L, Risteski M, Milašević N, Dimitrov G, Pašić A, Karaga M, Vrdoljak E.   +9 more
europepmc   +1 more source

Early ambulation and dhikr complementary therapies effect on intestinal peristaltic in post-open cholecystectomy patients. [PDF]

Rev Bras Enferm, 2023
Wilandika A, Gartika N, Nurfarida E.
europepmc   +1 more source

Influence of self-care using complementary and integrative therapies during the COVID-19 pandemic in children and adolescents aged 4 to 13 years with bruxism and temporomandibular disorders

, 2022
Ana Cristina Soares Caruso França Biagini, Carolina Paes Torres, Elisângela Aparecida da Silva Lizzi, Kranya Victória Díaz‐Serrano, Maria Cristina Borsatto   +4 more
openalex   +2 more sources

COMP–PMEPA1 axis promotes epithelial‐to‐mesenchymal transition in breast cancer cells

Molecular Oncology, EarlyView.
This study reveals that cartilage oligomeric matrix protein (COMP) promotes epithelial‐to‐mesenchymal transition (EMT) in breast cancer. We identify PMEPA1 (protein TMEPAI) as a novel COMP‐binding partner that mediates EMT via binding to the TSP domains of COMP, establishing the COMP–PMEPA1 axis as a key EMT driver in breast cancer.
Konstantinos S. Papadakos, Gilar Gorji‐bahri, Lejla Gradjan, Julia Zajac, Kacper Gil, Yvonne Thokozile Nduku, Anna M. Blom   +6 more
wiley   +1 more source

Complementary therapies for the management of attention deficit hyperactivity disorder in children: a scoping review. [PDF]

Rev Lat Am Enfermagem
Szychta LF, Sombra SEL, Lima GA, Ventura MWS, Oliveira BSB, Lima FET.   +5 more
europepmc   +1 more source

Current Status of Complementary Therapies Provided by Hospice Palliative Care in South Korea. [PDF]

J Hosp Palliat Care, 2021
Kwon S, Bak J, Kwon SH.
europepmc   +1 more source